To keep up-to-date with discussions you can subscribe to all postings by clicking the subscribe button below. You can manage your network notifications and set the frequency of emails in your communication preference area.
Return to previous page
I have been advised by an NMP studying for the independent prescriber qualification (v300) that her course tutor has said they should not prescribe nystatin oral suspension by the brand name because she is not covered by the NPF or the BNF to be prescribing Nystan ready mixed suspension. The reason given to her is it is not as stated in either BNF or NPF and does not come with a pipette therefore poses the risk of choking in babies.
We have investigated this before, and understood that pharmacists have an obligation to supply a suitable appliance, if one is not available with the product, for the patient to take an accurate dose.
I cannot answer to the other claim about Nystan Ready Mixed not being the same formula as the generic version, but it is news to me (and colleagues).
Does anyone have any definite facts about these two questions please?
Need help with networks?
If you have any queries about our networks you can get in touch via:
Networks – [email protected]
Local Practice Forums (LPFs) - [email protected]
If you need to report a post then please use the report button within a discussion.